Now Available- Michigan's Home Grown CBD! Contact Your Account Manager to Order or Search "CBD" to Order Online!

Industry News

Auburn continually updates our product portfolio, ensuring that we are offering the most current generics that are available in the market. What’s more, our commitment to consumer and product safety is unparalleled - we notify customers of manufacturer recalls immediately and our protocols align with FDA regulations.


With the merger of Mylan and Upjohn finally completed it didn’t take long for changes to be announced. The new company, known as Viatris (NASDAQ: VTRS) has announced that they will be closing Mylan’s first manufacturing plant located in Morgantown, WV. The plant, expected to close in July, employs over 1,600 people. Additionally, up to 15 other plants are expected to close throughout the world reducing their workforce by up to 20% or 9,000 people. Mylan’s CEO Heather Bresch who was involved in putting the merger together, recently stepped down from her position at Mylan. Her father coincidentally is former West Virginia Governor and current U.S. Senator Joe Manchin.

Teva recently received the first approval to market two strengths of generic Tirosint. This triggered a deal that Lannett had with brand manufacturer IBSA to launch all 12 strengths of their brand under the Lannett label. We have all strengths of the Authorized Generic (AG) in stock.

Hikma just received approval for their generic version of Advair Diskus. Prasco has been marketing the AG for almost two years through a deal with GSK. While Hikma’s product may be in short supply for a little while we expect to see market prices decline slightly.

Generic Chantix could be available at any time. Four companies are expected to receive approval and an AG is also possible. Brand sales in the U.S. were almost a billion dollars last year. Still no word as to when generic Restasis will be available but there are a few companies expecting it any day. Six manufacturers are expected to launch the first generic Northera caps at the end of February. Check with your Auburn Account Manager for information on these and more.

Make sure that you keep checking for the latest great deals on our weekly auctions. It’s a fun and easy way to save a lot of money!

image of pills falling out of bottle

Generic Product Launch Dates

Below you will find a list of anticipated new generic launch dates* along with the estimated availability. If you are interested in learning more about which items Auburn Pharmaceutical may carry in the future, please contact us to open your account.

Brand Name Generic Name # of players Estimated Availability*
Chantix Varenicline Multiple 4Q 2020
Vascepa Icosapent Multiple TBD 2020
Saphris Asenapine Maleate Multiple December 2020
Absorica Isotretinoin 1-2 Players December 2020
*This information is intended to provide you with the latest industry news around generic drug launch dates. Please note, there is no guarantee that Auburn Pharmaceutical will supply the listed products. Product release dates are subject to change by evolving market conditions. Launch dates are anticipated, not guaranteed.

Upcoming Events & Promotions

Stay Tuned For Upcoming Events!